chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest Pressure developed 2 days post-vaccine. Admitted for elevated troponins, myopericarditis. Improved on NSAIDs, colchicine.
allergic reaction; she couldn't get warm; chills; rash all over; swelling in her arms and legs; diarrhea; Extremely tired; headache; Nausea; her blood pressure was taken and it was 165/40.; her blood pressure was taken and it was 165/40.; throwing up; dizzy; Numb on body on right side; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) dose 1 via an unspecified route of administration, administered in arm left on 04May2021 08:30 (Lot Number: EW0172) as 1st dose, single for covid-19 immunisation. The patient medical history was reported as none. There were no concomitant medications. Patient had investigation assessment. No additional administered vaccines. No Prior vaccinations within 4 weeks. The patient had an allergic reaction to the first dose of the Pfizer covid 19 vaccine and wanted to know if she should take the other one. The patient had throwing up, numb on body on right side, dizzy, nausea on 04May2021; headache and extremely tired on 05May2021; diarrhea on 06May2021; rash all over, swelling in arms and legs, chills on 08May2021; her blood pressure was taken and it was 165/40 mmHg on 04May2021, she couldn't get warm on an unspecified date. Events did not require a visit to emergency room or physician office. The outcome of events rash all over, swelling in arms and legs, chills was not recovered; event throwing up was recovered on 04May2021; numb on body on right side was recovered on 06May2021; events diarrhea, headache and extremely tired was recovered on 07May2021; events dizzy and nausea was recovered in May2021; of other events was unknown.
I have had some nasal congestion but its allergy; I have had some nasal congestion but its allergy; This is a spontaneous report from a Pfizer Sponsored program. This is a spontaneous report from a contactable Consumer (patient). A 40-year-old female received bnt162b2 (Pfizer-biontech COVID-19 vaccine, Solution for injection, Batch/lot number: LNER8737) via an unspecified route of administration on 07Apr2021 as DOSE 1, SINGLE for COVID-19 immunization (at an age of 40 years). The patient medical history was nasal congestion but its allergy and concomitant were not reported . On an unknown date in Apr2021 the patient had experienced some nasal congestion but its allergy. Patient has an query ,wanted to ask her second dose is scheduled tomorrow for the last week she have had some nasal congestion but its allergy. She gets this every year. She was not experiencing any other symptoms or anything like that. she wants to make sure its ok for her to still get her second vaccine. The clinical outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.          No follow-up attempts are needed. No further information is expected.
Sore arm,  red about 3 inch in diameter around injection site, severe itching, swollen,  hard/firm to the touch
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 12-NOV-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R015432, expiration date 15-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
This spontaneous report was received from a female patient of unknown age regarding herself. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. On an unknown date, after the vaccination, the patient experienced a cold, watery eyes and a stuffy nose. Product quality complaint (PQC) was filed as the patient thought the color of ZOSTAVAX that was administered, did not look the way it was described in the product information (PI). The outcome of cold, watery eyes and a stuffy nose was unknown. The relatedness for cold, watery eyes and a stuffy nose was unknown for ZOSTAVAX. Additional information is not expected.
2 weeks after the first shot I had a rash on my arm. Exactly 2weeks after second vaccine my feet swelled up and started hurting so bad I couldn?t walk or stand. Three days later my muscles hurt so bad I went to emergency room two different times because pain was so bad. I had to have help walking getting dressed I lost 25lbs in those two weeks. Several trips to different doctors to try and figure out what was happening . I?ve never been sick before in my life .
Patient called 2 hours after having immunization stating she was having some swelling specifically around the eye-no issues with breathing or mouth/throat area.
Started feeling queasy, nauseous, headaches, fast heart rate, very similar reaction to when I go into anaphylactic shock when I get severe allergic reaction. I waited it out and did not seek additional help.
Pt phoned at 8:30 AM on 7/19/07 stating approx. 2 h after immunization, she experienced pain at injection site which radiated to her neck and (L) arm that evening. Denies edema, erythema or exudate.
Employee reported that four days after receiving second dose of pre-exposure Imovax vaccine he developed a flat, red, non-puritic rash on the inner arms and legs. He had moderate joint pain in his hands, neck, elbow, knees and ankles. No fever, hives or swelling of face, etc. Called his private physician, but was not able to be seen before symptoms resolved (~3 days). Joint pain relieved by ASA, but not ibuprofen. Had a headache he related to the stiffness in his neck. Also had malaise. Reported to NIPINFO and was recommended to complete the rabies pre-exposure series.
Rash at the injection site; Redness at the injection site; Raised at the injection site; Broke out at the injection site; Itchiness at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE LACERATION (Broke out at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Raised at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (History of anaphylactic reaction to bug bite and medication). Concurrent medical conditions included Acid reflux (oesophageal). Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) for Acid reflux (oesophageal).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE LACERATION (Broke out at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Raised at the injection site). On 19-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Vaccination site rash, Vaccination site erythema, Vaccination site laceration, Vaccination site swelling and Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE LACERATION (Broke out at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Raised at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
felt nothing on the day of and the day after.  Halfway through Saturday, the injection site throbbed and was warm.  During the outing with my family, I started with a severe headache. Saturday night, when i got home, I had chills.  During the night, I was awoke by my knees throbbing and my sacro-illiac joint on fire.  This continues through Sunday..and progressed to nausea and vomiting.  It was the worst pain.  It lasted through Monday night into Tuesday.
Patient discharged after (4) day inpatient stay 11/12-11/16/21 Patient is an otherwise health 38 YO woman who was admitted with acute hypoxia related to COVID-19 pneumonia on 11/12/21. She had been fully vaccinated prior to infection. Upon admission she was treated with oral Decadron and IV remdesivir daily. With treatment, her supplemental O2 needs improved and she was weaned off of all supplemental O2 at rest. With ongoing improvement in her symptoms, she was evaluated by Pulmonary Rehab who determined that she needed 1 Lpm supplemental O2 with activity, anticipating that this need will decrease over time. She was deemed stable for discharge on 11/16/21.
numbness lt side of face 24 hrs (within) 5th cranial nerve inflamation w/in 4 day; hospitalization 1 wk w/treatment of steroids; hospitalization x 12 days gate was off, no temp, fatigue general body weakness; dx MS
Had amenorrhea since beginning oral contraceptives over 15 years ago. 2 months after being fully vaccinated, began getting extended length periods again. Also, significant increase in breast size.
Vasovagal syncope Pt fell face first out of the chair approximately 10 minutes post covid vaccine. Pt became pale,diaphortic , pupils dilated and non-responsive. No chest rise/fall noted. Nurse could not palpate a pulse. Epi pen administered in right thigh. Pt responded to epi pen and sat up on his own . Emergency alert called overhead on the PA System. ED staff responded and transported pt via stretcher to  ED.  Pt discharged to home.
her nose was stuffy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHINITIS ALLERGIC (non-serious), outcome "unknown", described as "her nose was stuffy".  Additional information: It was reported that patient was due for 2nd dose the 20th. Patient also stated that her mother and friend had the vaccine, and their allergies were acting up. Her mom says her nose was stuffy. Her boyfriend had his arm sore and couldn't move it but was ok the next day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT REFERS THAT 3 DAYS AFTER VACCINATION SHE EXPERIENCED HEADACHE,VOMITING AND DIARRHEA.
Patient received 1st dose of Moderna on 04/21/2021 and second dose on 5/19/2021. Both doses were prior to patient turning 18 years old.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 68-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included cold sore (herpetic). On 21st August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) 50 mcg/mg. In August 2018, less than 2 weeks after receiving SHINGRIX, the patient experienced feeling sad, difficulty sleeping, fever and foggy feeling in head. On 30th August 2018, the patient experienced shingles, blister and pustule. On an unknown date, the patient experienced general body pain. The patient was treated with lidocaine hydrochloride, antibiotics nos, anti-inflammatory/antirheumatic products, antivirals for systemic use and hydrocodone. On an unknown date, the outcome of the shingles, blister, feeling sad, difficulty sleeping, fever, foggy feeling in head, pustule and general body pain were recovering/resolving. It was unknown if the reporter considered the shingles, blister, feeling sad, difficulty sleeping, fever, foggy feeling in head, pustule and general body pain to be related to SHINGRIX. Additional information received as follows: The case was reported by the patient's husband. At 15:00 pm, the patient received SHINGRIX on the right arm. The patient experienced body pain from upper leg to shoulder on right side of the body. On 27th August 2018, the patient was taken to an emergency room. She was given antibiotics and anti-inflammatory medication and discharged on the same day. The event arthritis was ruled out. The patient experienced blisters and pus. The blisters were present on upper right leg joint and back. She had fever, fogginess, trouble sleeping and sadness due to prolonged period of pain. On 31st August 2018, she went to her primary care physician. The physician said that it was Shingles like viral infection, and therefore the physician started treatment for Shingles. She was started on antiviral medication, and hydrocodone for the pain. She also applied lidocaine patch for the pain. On 13th September 2018, the patient underwent blood test and she was waiting for test results at the reporting time. The reporter gave permission to contact the patient's physician. No further details were provided.
About 6 hours post injection, with only a small amount of muscle soreness in the injected arm, I was suddenly very very dizzy. I ran from my living room to my bedroom and got under the sheets, I was very very cold. My whole body was twitching violently, and I had extreme muscle pain. Joints popped like knuckles cracking that I wouldn't normally be able to pop. This lasted for about 10 minutes very violently and then calmed down over another 10, and I just felt very very feverish. I felt numb all over but I was shivering a little. Moving was very hard and my whole back was very sore, with the injection arm in a little extra pain. Fell asleep until about 7:30 am, woke up still a little feverish. I have had waves of extreme dizziness and muscle aches continuing even to today a couple days later. I am also experiencing a rather persistent headache in the very center of my head, making it hard to think. I lose track of my thoughts and it feels like I can't focus, this seems to be improving gradually over time. treatment only included extra fluid intake and over the counter pain killers
Escalary erythema, edema, itchy, 11 cm X 8 cm skin lesion
Fatigue, following by chills, fever, sweating, shivering, headache. Felt like vomiting, but didn't. Slight pain at injection site. Fatigue and headache lasted about 3 days. Fever lasted about 24-36 hours. Missed 2 days of work.
Patient presented to pharmacy the morning following vaccination (8/21/21) and said she had swelling around her eyes (mainly around eyebrow area with dropping) when she went to bed the night of the vaccination (8/20/21). When patient presented she stated that the reaction had improved since the previous night and the swelling was no longer prominently visible. No other reaction was reported upon questioning.
urticarial rash on buttockS Narrative:  Per RN note 2/1/21: "pt walk in to clinic asking for appt with PCP for "bumps" on extremities after receiving COVID 19 vaccine. pt states the small red, raised areas appeared 2 days after the vaccination. She has a few  remaining single hives on upper legs, arm, and warm area of body. She states better with benadryl." Per PCP note 2/3/21:  She also reports she received COVID vaccine 2 weeks ago with development of urticarial rash on buttocks, lower and upper extremities sparing the trunk, back and face, palms and soles  about 2 days after injection and is persistent. She states lesions are evanescent  lasting around 24-48h and are pruritic both during day and night, somewhat controlled with over the counter Bendaryl." Allergist started loratadine 10mg qdaily, prednisone 20mg bid x 4 days
This spontaneous report was received from a physician referring to a 70 year old male patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unspecified date in 2012, reported as about 5 years ago the patient was vaccinated with ZOSTAVAX for prophylaxis (dose, route of administration, lot number and expiration date were not reported). It was reported that the patient presented to the physician over the weekend with shingles. The reporter stated that the patient was prescribed a course of anti-virals on an unspecified date. At the time of the report, the outcome of shingles was unknown. Additionally, the reporter did not provide causality assessment between the event and vaccination with ZOSTAVAX.
got vaccine 10/26/21, shoulder pain has not resolved, notified pharmacy 11/15/21, seeked dr and ultrasound care
At injection site - hotness; Skin hardness at injection site; Extreme pain at injection site; Redness at injection site that has spread; This is a spontaneous case, initially received from other health professional via agency (case ID: SEQ19-04875) on 16-Oct-2019, concerning a female patient of an unknown age.   The patient's medical history and concomitant medications were not reported.   On an unknown date, the patient was administered Afluria Quadrivalent [influenza vaccine, dose: 0.5 ml, batch number: P100112490, expiration date: 11-Jun-2020, route of administration and anatomical location: not reported] for an influenza prophylaxis.  On an unknown date, after vaccination, the patient experienced hotness, extreme pain, skin hardness at injection site and redness at injection site that had spread.   On 24-Sep-2019, the reporter stated that the patient was doing well.  The outcome of all the events was recovered, on an unspecified date.  The reporter did not provide seriousness and causality assessment.  The case is linked to 201905307, 201905317, 201905318, 201905319, 201950320, 201905321, 201905323, 201905324 and 201905325 due to same reporter.  Follow up received from other health professional via agency (SEQ19-05499) on 24-Oct-2019: The reporter stated that all vaccine recipients were doing well. The outcome of all events updated to 'Recovered/resolved'. Narrative amended accordingly.  Company comment: The patient experienced vaccination site warmth, vaccination site induration, vaccination site pain and vaccination site erythema after vaccination with the suspect product Afluria Quadrivalent. Chronology is plausible. No medical history, diagnostic findings and concomitant medications were reported. Considering all the above mentioned, causal role of the suspect product cannot be totally excluded and is assessed as possibly related.; Sender's Comments: The patient experienced vaccination site warmth, vaccination site induration, vaccination site pain and vaccination site erythema after vaccination with the suspect product Afluria Quadrivalent. Chronology is plausible. No medical history, diagnostic findings and concomitant medications were reported. Considering all the above mentioned, causal role of the suspect product cannot be totally excluded and is assessed as possibly related.
had a mini stroke; was stuttering; wasn't feeling good; blood pressure was high; This spontaneous case was reported by a consumer and describes the occurrence of TRANSIENT ISCHAEMIC ATTACK (had a mini stroke) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced TRANSIENT ISCHAEMIC ATTACK (had a mini stroke) (seriousness criterion medically significant), DYSPHEMIA (was stuttering), FEELING ABNORMAL (wasn't feeling good) and HYPERTENSION (blood pressure was high). On 23-Mar-2021, TRANSIENT ISCHAEMIC ATTACK (had a mini stroke), DYSPHEMIA (was stuttering), FEELING ABNORMAL (wasn't feeling good) and HYPERTENSION (blood pressure was high) had resolved.            The Patient has not provided with any Treatment medications. There are no concomitant medications provided.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
bivalent gray cap was used to booster patient who was not yet 12 years at the time.
The next morning after the vaccine I woke up with very bad hives and still to date I am still experiencing them. They began to subside slightly but after my Moderna booster they returned.
pt recv vax 15SEP95 & 13MAR97 pt devel five lesions;pt had no other sx;No further details were provided;
tightness in chest-very difficult to breath- very bad wheezing in chest-extreme tiredness-extreme headache
The patient calmly walked out to seating area and sat down after receiving vaccine. The patient did state that he "did not like needles". After a few minutes the patient went pale, started sweating, then lost consciousness for about a minute. During that time patient was unresponsive. No vitals were taken. I ran to get an Epipen and by the time I came back the patient was alert and responsive albeit a little shaky. Patient was given water, a small Cliff bar, and an orange soda. After about half an hour, the patient stated he was fine and left.
73 Y/O M w/ hx of HTN, DM, PAST PERICARDITIS. PT states onset of substernal chest px "like the pericarditis" shortly after vaccine #1. VS w/ elevated BP (175/84, reports baseline of ~130). Briefly observed, initially reported some decrease in px intensity, but repeat BP w/ persistent elevation (188/87) and shift in chest px to left side 5-6/10 px. PT alert NAD apparent, other VS w/in normal limits. EMS/ED notified of PT transfer. BP taken by EMS= 160.
Pt was itchy at injection site following vaccine, then developed baseball size discoloring at injection site (different shade of beige).
Moderna COVID-19 Vaccine EUA Got the first dose on Saturday 4/3/21. Just sore arm that day and next couple of days. On Sunday 4/11/21 though, covid arm, red rash and itchy on left arm near the site of injection. Treating with cold pack and OTC cortisone ointment to help relieve itchiness.
Vaccine dose 1 given 2/25/2021 Pfizer lot # EN6203 Pt was hospitalized for Covid 19 7/29/2022-8/2/2022 at local Medical center.